Otsuka Co. (OTCMKTS:OSUKF – Get Free Report) was the target of a significant decrease in short interest in the month of April. As of April 30th, there was short interest totaling 420,688 shares, a decrease of 49.1% from the April 15th total of 826,439 shares. Based on an average daily trading volume, of 2 shares, the short-interest ratio is presently 210,344.0 days.
Otsuka Stock Performance
OSUKF remained flat at $20.77 during trading on Friday. The company has a fifty day simple moving average of $20.76 and a two-hundred day simple moving average of $20.69. Otsuka has a 1-year low of $19.00 and a 1-year high of $21.57.
Otsuka Company Profile
Otsuka Holdings Co, Ltd., traded as OSUKF on the OTC Market, is a global healthcare group headquartered in Tokyo, Japan. The company operates through its principal subsidiary, Otsuka Pharmaceutical Co, Ltd., and is primarily engaged in the research, development and commercialization of pharmaceutical products and nutraceuticals. Its product portfolio spans central nervous system therapies, cardiovascular and metabolic treatments, nephrology, and oncology, alongside a range of consumer wellness goods such as nutritional beverages and dietary supplements.
The origins of the Otsuka group date back to 1921 with the founding of its predecessor firm, and in 2008 the current holding company structure was established to streamline governance and strategic direction.
Featured Stories
- Five stocks we like better than Otsuka
- 3 Stocks to Own If Gas Prices Keep Rising
- 3 Crucial Aerospace Component Makers That Analysts Love
- Alphabet’s Googlebook Brings Gemini AI to PC Hardware
- Peloton Stock Gives Back Gains After Upbeat Earnings Report
Receive News & Ratings for Otsuka Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Otsuka and related companies with MarketBeat.com's FREE daily email newsletter.
